CO News and Press, Global Cord Blood Corporation From 08/31/21

Global Cord Blood Corporation (CO) Q1 2022 Earnings Conference Call August 31, 2021 08:00 AM ET Company Participants Cathy Bai - VP of Corporate Finance Albert Chen - Chief Financial Officer Presentation Operator Ladies and gentlemen, welcome everyone to Global Cord Blood Corporation Earnings...

Image source: The Motley Fool. Global Cord Blood Corporation (NYSE: CO) Q1 2022 Earnings Call Aug 31, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Global Cord Blood Corporation (CO) Q1 2022 Earnings Call Transcri...

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022 PR Newswire 1Q22 Added 19,673 New Subscribers Revenues Up 12.2% YoY to RMB315.2 Million ( $48.8 Million ) Gross Profit Up 12.6% YoY to RMB267.3 Million ...

Global Cord Blood Corporation to Report First Quarter Fiscal 2022 Financial Results Earnings Call Scheduled for 8:00 a.m. ET on August 31, 2021 PR Newswire HONG KONG , Aug. 25, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), C...

Surging COVID-19 cases and rising inflation are causing market volatility, making highly priced stocks susceptible to a correction in the near term. But, as a corollary to this, we think fundamentally sound and low-priced stocks Centerra Gold (CGAU), Alliance Resource (ARLP), Global Cord Bloo...

DENVER, CO - ( NewMediaWire ) - August 03, 2021 - DEFY , a leader in premium performance beverages and wellness products, today announces the launch of DEFY Water in more than 150  King Soopers  stores throughout Colorado. DEFY Water is an ionized alkaline pH 9.5+ water in...

Global Cord will benefit from China’s tutoring regulatory changes due to higher disposable income for expecting parents and increased newborns. The company is experiencing an acceleration in new subscribers and revenue growth as China’s economy re-opens. Policy risks...

Global Cord Blood Corporation Files Annual Report on Form 20-F PR Newswire HONG KONG , July 29, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

LendingClub LC +38% on Q2 earnings. Cocrystal Pharma (NASDAQ:COCP) +26% SARS-CoV-2 3CL protease lead CDI-45205 demonstrates Broad-Spectrum activity against the SARS-CoV-2 Delta and Gamma Variants Flora Growth (NASDAQ:FLGC) +20%. Acer Therapeutics (NASDAQ:ACER) +21%. NanoVibroni...

Global Cord Blood had a decent quarter, with subscriber growth improving both YoY and QoQ. This company is very cheap with 146% net cash to market cap. 24% EPS CAGR over the last 5-year period. Changes in birthing policy in China - will bode well for the company. A market ...